PwC Will Pay $96M To Settle Valeant Investor Class Claims
PricewaterhouseCoopers LLP has agreed to pay $96 million to end a long-running securities fraud suit over an alleged market manipulation scheme by Bausch predecessor Valeant Pharmaceuticals, the plaintiffs told a New...To view the full article, register now.
Already a subscriber? Click here to view full article